Transvenous extraction of implantable cardioverter-defibrillator leads under advisory—A comparison of Riata, Sprint Fidelis, and non-recalled implantable cardioverter-defibrillator leads

Author:

Brunner Michael P.,Cronin Edmond M.,Jacob Jessen,Duarte Valeria E.,Tarakji Khaldoun G.,Martin David O.,Callahan Thomas,Borek P. Peter,Cantillon Daniel J.,Niebauer Mark J.,Saliba Walid I.,Kanj Mohamed,Wazni Oussama,Baranowski Bryan,Wilkoff Bruce L.

Publisher

Elsevier BV

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference20 articles.

1. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities

2. Implantable cardioverter-defibrillator utilization;Camm;Europace,2011

3. Early failure of a small-diameter high-voltage implantable cardioverter-defibrillator lead;Hauser;Heart Rhythm,2007

4. United States Food and Drug Administration. Medtronic Inc. Sprint Fidelis defibrillator leads class I recall. Available at: http://www.fda.gov/MedicalDevices/Safety/ListofRecalls/ucm062377.htm. Accessed November 11, 2012.

5. St. Jude Medical. United States Riata lead communication. Available at: http://www.riatacommunication.com. Accessed September 10, 2012.

Cited by 57 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3